-
Stable cellular models of nuclear receptor PXR for high-throughput evaluation of small molecules.
Toxicology in vitro : an international journal published in association with BIBRA 20181001
-
Efficacy of anti-inflammatory, antibiotic and pleiotropic agents in reversing nitrogen mustard-induced injury in ex vivo cultured rabbit cornea.
Toxicology letters 20180901
-
Improvement of hyperglycemia in a murine model of insulin resistance and high glucose- and inflammasome-mediated IL-1β expressions in macrophages by silymarin.
Chemico-biological interactions 20180625
-
Silymarin attenuated paraquat-induced cytotoxicity in macrophage by regulating Trx/TXNIP complex, inhibiting NLRP3 inflammasome activation and apoptosis.
Toxicology in vitro : an international journal published in association with BIBRA 20180201
-
Hepatoprotective effect of 10% ethanolic extract from Curdrania tricuspidata leaves against ethanol-induced oxidative stress through suppression of CYP2E1.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20171001
-
Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism.
Chemico-biological interactions 20170801
-
Modulatory effect of silymarin on nuclear factor-erythroid-2-related factor 2 regulated redox status, nuclear factor-κB mediated inflammation and apoptosis in experimental gastric ulcer.
Chemico-biological interactions 20170801
-
Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan.
Toxicology and applied pharmacology 20170715
-
Natural antioxidant flavonoids in formalin-induced mice paw inflammation; inhibition of mitochondrial sorbitol dehydrogenase activity.
Journal of biochemical and molecular toxicology 20170701
-
Chrysin and silibinin sensitize human glioblastoma cells for arsenic trioxide.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20170701
-
The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Chemico-biological interactions 20170601
-
Hesperetin derivative-14 alleviates inflammation by activating PPAR-γ in mice with CCl(4)-induced acute liver injury and LPS-treated RAW264.7 cells.
Toxicology letters 20170515
-
Silymarin protects against acrylamide-induced neurotoxicity via Nrf2 signalling in PC12 cells.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20170401
-
Hepatoprotective effect of 2'-O-galloylhyperin against oxidative stress-induced liver damage through induction of Nrf2/ARE-mediated antioxidant pathway.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20170401
-
Protective Effects of Ecklonia stolonifera Extract on Ethanol-Induced Fatty Liver in Rats.
Biomolecules & therapeutics 20161101
-
Tangeretin attenuates cisplatin-induced renal injury in rats: Impact on the inflammatory cascade and oxidative perturbations.
Chemico-biological interactions 20161025
-
Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells.
Journal of clinical and experimental hepatology 20160901
-
Hepatoprotective effects of sesamol loaded solid lipid nanoparticles in carbon tetrachloride induced sub-chronic hepatotoxicity in rats.
Environmental toxicology 20160501
-
Taurine zinc solid dispersions attenuate doxorubicin-induced hepatotoxicity and cardiotoxicity in rats.
Toxicology and applied pharmacology 20151115
-
Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Chemico-biological interactions 20151005
-
Effects of Melatonin-Aided Therapy on the Glutathione Antioxidant System Activity and Liver Protection.
Journal of biochemical and molecular toxicology 20151001
-
Coordinated regulation of scopoletin at adipose tissue-liver axis improved alcohol-induced lipid dysmetabolism and inflammation in rats.
Toxicology letters 20150917
-
Assessment of hepatoprotective potential of N. indicum leaf on haloalkane xenobiotic induced hepatic injury in Swiss albino mice.
Chemico-biological interactions 20150625
-
Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice.
Chemico-biological interactions 20150325
-
Blockade of lipid accumulation by silibinin in adipocytes and zebrafish.
Chemico-biological interactions 20150205
-
Silibinin combination with arsenic strongly inhibits survival and invasiveness of human prostate carcinoma cells.
Nutrition and cancer 20150101
-
Protective role of silymarin against manganese-induced nephrotoxicity and oxidative stress in rat.
Environmental toxicology 20141001
-
Hepatoprotective effects of fermented field water-dropwort (Oenanthe javanica) extract and its major constituents.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20140501
-
The binding of silibinin to ERp57.
Chemico-biological interactions 20140425
-
Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation.
Chemico-biological interactions 20140325
-
Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.
Cardiovascular toxicology 20140301
-
Silymarin prevents the toxicity induced by benzo(a)pyrene in human erythrocytes by preserving its membrane integrity: an in vitro study.
Environmental toxicology 20140201
-
Ascorbic acid suppresses endotoxemia and NF-κB signaling cascade in alcoholic liver fibrosis in guinea pigs: a mechanistic approach.
Toxicology and applied pharmacology 20140115
-
Saussurea lappa alleviates inflammatory chemokine production in HaCaT cells and house dust mite-induced atopic-like dermatitis in Nc/Nga mice.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20140101
-
Leukocyte production of inflammatory mediators is inhibited by the antioxidants phloretin, silymarin, hesperetin, and resveratrol.
Mediators of inflammation 20140101
-
Silibinin as a potential therapeutic for sulfur mustard injuries.
Chemico-biological interactions 20131205
-
Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism.
Molecular and cellular biochemistry 20131201
-
Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).
Toxicological sciences : an official journal of the Society of Toxicology 20131201
-
Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking.
Cellular microbiology 20131101
-
Silymarin protects from varicocele-induced damages in testis and improves sperm quality: evidence for E2f1 involvement.
Systems biology in reproductive medicine 20131001
-
Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats.
Toxicology letters 20130523
-
Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells.
Toxicology in vitro : an international journal published in association with BIBRA 20130301
-
Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated wistar rats.
Journal of agricultural and food chemistry 20130213
-
Biochemical and molecular mechanisms of N-acetyl cysteine and silymarin-mediated protection against maneb- and paraquat-induced hepatotoxicity in rats.
Chemico-biological interactions 20130125
-
Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice.
Cancer letters 20121229
-
Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
Medical oncology (Northwood, London, England) 20121201
-
CHOP down-regulates cFLIP(L) expression by promoting ubiquitin/proteasome-mediated cFLIP(L) degradation.
Journal of cellular biochemistry 20121201
-
Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Cellular signalling 20121201
-
Silibinin ameliorates arsenic induced nephrotoxicity by abrogation of oxidative stress, inflammation and apoptosis in rats.
Molecular biology reports 20121201
-
Nitric oxide (•NO) generation but not ROS plays a major role in silibinin-induced autophagic and apoptotic death in human epidermoid carcinoma A431 cells.
Free radical research 20121101
-
Silibinin for cyclopeptide mushroom poisonings.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20121101
-
Protection by silibinin against experimental ischemic stroke: up-regulated pAkt, pmTOR, HIF-1α and Bcl-2, down-regulated Bax, NF-κB expression.
Neuroscience letters 20121031
-
Silibinin attenuates allergic airway inflammation in mice.
Biochemical and biophysical research communications 20121026
-
Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
Molecular carcinogenesis 20121001
-
Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries.
Toxicology and applied pharmacology 20121001
-
In vivo evaluation of silybin nanosuspensions targeting liver.
Journal of biomedical nanotechnology 20121001
-
Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells.
Epigenetics 20121001
-
Hepatoprotective and anti-inflammatory effects of silibinin on experimental preeclampsia induced by L-NAME in rats.
Life sciences 20120904
-
Silibinin regulates gene expression, production and secretion of mucin from cultured airway epithelial cells.
Phytotherapy research : PTR 20120901
-
Long-term administration of Silymarin augments proinflammatory mediators in the hippocampus of rats: evidence for antioxidant and pro-oxidant effects.
Human & experimental toxicology 20120901
-
P53-mediated GSH depletion enhanced the cytotoxicity of NO in silibinin-treated human cervical carcinoma HeLa cells.
Free radical research 20120901
-
Mulberry water extracts (MWEs) ameliorated carbon tetrachloride-induced liver damages in rat.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120901
-
Antioxidant effect of silymarin on paraquat-induced human lung adenocarcinoma A549 cell line.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120901
-
Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response.
Neurochemical research 20120901
-
Silibinin, a natural flavonoid, modulates the early expression of chemoprevention biomarkers in a preclinical model of colon carcinogenesis.
International journal of oncology 20120901
-
Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Oncology reports 20120901
-
Silibinin modulates the NF-κb pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women.
Journal of reproductive immunology 20120901
-
Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model.
Human & experimental toxicology 20120801
-
The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Apoptosis : an international journal on programmed cell death 20120801
-
Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
Molecular nutrition & food research 20120801
-
Hepatitis C therapy in non-genotype 1 patients: the near future.
Journal of viral hepatitis 20120801
-
High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy.
Journal of viral hepatitis 20120801
-
Perioperative polyphenon E- and siliphos-inhibited colorectal tumor growth and metastases without impairment of gastric or abdominal wound healing in mouse models.
Surgical endoscopy 20120701
-
In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds.
Parasitology research 20120701
-
Injectable and biodegradable poly(organophosphazene) gel containing silibinin: its physicochemical properties and anticancer activity.
Journal of pharmaceutical sciences 20120701
-
Silibinin inhibits tumor growth in a murine orthotopic hepatocarcinoma model and activates the TRAIL apoptotic signaling pathway.
Anticancer research 20120701
-
Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo.
Journal of medicinal chemistry 20120614
-
Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones.
Parasitology research 20120601
-
Complementary and alternative medicines in prostate cancer: from bench to bedside?
The oncologist 20120601
-
Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
Translational research : the journal of laboratory and clinical medicine 20120601
-
Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways.
Journal of cellular biochemistry 20120501
-
Silibinin potentially protects arsenic-induced oxidative hepatic dysfunction in rats.
Toxicology mechanisms and methods 20120501
-
Understanding silibinin's modes of action against HCV using viral kinetic modeling.
Journal of hepatology 20120501
-
Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120501
-
[Acute hepatic failure after ingestion of mushrooms].
Der Internist 20120501
-
Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells.
Cell biochemistry and function 20120401
-
Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120401
-
Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide.
Biochemical and biophysical research communications 20120316
-
Improvement of cerebellum redox states and cholinergic functions contribute to the beneficial effects of silymarin against manganese-induced neurotoxicity.
Neurochemical research 20120301
-
Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45α-dependent manner.
Carcinogenesis 20120301
-
P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK.
Free radical research 20120301
-
Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.
The journal of pain : official journal of the American Pain Society 20120301
-
Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.
Neurochemical research 20120201
-
Metabolic effects of silibinin in the rat liver.
Chemico-biological interactions 20120125
-
Colon cancer chemopreventive efficacy of silibinin through perturbation of xenobiotic metabolizing enzymes in experimental rats.
European journal of pharmacology 20120115
-
Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Journal of cellular biochemistry 20120101
-
Synergistic antibacterial effect between silibinin and antibiotics in oral bacteria.
Journal of biomedicine & biotechnology 20120101
-
Silibinin is a potent sensitizer of UVA radiation-induced oxidative stress and apoptosis in human keratinocyte HaCaT cells.
Photochemistry and photobiology 20120101
-
In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles.
International journal of nanomedicine 20120101
-
In vivo recovery effect of silibinin treatment on streptozotocin-induced diabetic mice is associated with the modulations of Sirt-1 expression and autophagy in pancreatic β-cell.
Journal of Asian natural products research 20120101
-
Natural terpenes prevent mitochondrial dysfunction, oxidative stress and release of apoptotic proteins during nimesulide-hepatotoxicity in rats.
PloS one 20120101
-
Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling.
PloS one 20120101
-
Dual effects of silibinin treatment on autophagy-regulated dermal apoptosis retardation and epidermal apoptosis up-regulation in UVB-induced skin inflammation.
Journal of Asian natural products research 20120101
-
Metabolic acidosis during treatment of mushroom poisoning: a diagnostic pitfall.
Internal medicine (Tokyo, Japan) 20120101
-
Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.
PloS one 20120101
-
Silibinin attenuates sulfur mustard analog-induced skin injury by targeting multiple pathways connecting oxidative stress and inflammation.
PloS one 20120101
-
The correlation between NF-κB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis.
Fundamental & clinical pharmacology 20111201
-
Synergistic effects between silibinin and antibiotics on methicillin-resistant Staphylococcus aureus isolated from clinical specimens.
Biotechnology journal 20111101
-
Silibinin induced-autophagic and apoptotic death is associated with an increase in reactive oxygen and nitrogen species in HeLa cells.
Free radical research 20111101
-
Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells.
Anticancer research 20111101
-
Neuroprotective effect of silibinin in diabetic mice.
Neuroscience letters 20111031
-
The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats.
Molecules (Basel, Switzerland) 20111012
-
Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Molecular carcinogenesis 20111001
-
Interruption of mitochondrial complex IV activity and cytochrome c expression activated O₂·⁻-mediated cell survival in silibinin-treated human melanoma A375-S2 cells via IGF-1R-PI3K-Akt and IGF-1R-PLC γ-PKC pathways.
European journal of pharmacology 20111001
-
Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells.
Apoptosis : an international journal on programmed cell death 20111001
-
The cytotoxicity of OPA-modified CdSe/ZnS core/shell quantum dots and its modulation by silibinin in human skin cells.
Journal of biomedical nanotechnology 20111001
-
Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.
Behavioural brain research 20110801
-
Silibinin mode of action against hepatitis C virus: a controversy yet to be resolved.
Hepatology (Baltimore, Md.) 20110801
-
Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.
Cancer prevention research (Philadelphia, Pa.) 20110801
-
Role of ROS in the protective effect of silibinin on sodium nitroprusside-induced apoptosis in rat pheochromocytoma PC12 cells.
Free radical research 20110701
-
Effect of silybin on high-fat-induced fatty liver in rats.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110701
-
Identification and initial SAR of silybin: an Hsp90 inhibitor.
Bioorganic & medicinal chemistry letters 20110501
-
[Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug].
Nihon rinsho. Japanese journal of clinical medicine 20110501
-
Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis.
Toxicology and applied pharmacology 20110415
-
Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice.
Carcinogenesis 20110401
-
Silybin inhibits interleukin-1β-induced production of pro-inflammatory mediators in canine hepatocyte cultures.
Journal of veterinary pharmacology and therapeutics 20110401
-
Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20110401
-
Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.
Journal of pineal research 20110301
-
Inhibiting NF-κB activation and ROS production are involved in the mechanism of silibinin's protection against D-galactose-induced senescence.
Pharmacology, biochemistry, and behavior 20110301
-
Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins.
Journal of cellular biochemistry 20110301
-
Silibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies.
Clinical cancer research : an official journal of the American Association for Cancer Research 20110215
-
Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl(4)-intoxicated mice.
Toxicology 20110204
-
Silibinin: a novel inhibitor of Aβ aggregation.
Neurochemistry international 20110201
-
Preparation and effects of 2,3-dehydrosilymarin, a promising and potent antioxidant and free radical scavenger.
The Journal of pharmacy and pharmacology 20110201
-
Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle.
Toxicologic pathology 20110201
-
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20110201
-
Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies.
European journal of pharmacology 20110110
-
Influence of commonly used clinical antidotes on antioxidant systems in human hepatocyte culture intoxicated with alpha-amanitin.
Human & experimental toxicology 20110101
-
Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway.
Cancer investigation 20110101
-
Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways.
Biological & pharmaceutical bulletin 20110101
-
Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria.
Molecular cancer therapeutics 20110101
-
Silibinin activated ROS-p38-NF-κB positive feedback and induced autophagic death in human fibrosarcoma HT1080 cells.
Journal of Asian natural products research 20110101
-
Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.
PloS one 20110101
-
Silibinin induces apoptosis via calpain-dependent AIF nuclear translocation in U87MG human glioma cell death.
Journal of experimental & clinical cancer research : CR 20110101
-
Prospective randomized clinical trial assessing the efficacy of Denamarin for prevention of CCNU-induced hepatopathy in tumor-bearing dogs.
Journal of veterinary internal medicine 20110101
-
Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice.
Cardiovascular diabetology 20110101
-
Natural antioxidants and vascular calcification: a possible benefit.
Journal of nephrology 20110101
-
Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells.
International journal of molecular sciences 20110101
-
[Some issues of death cap (Amanita phalloides) poisoning based on cases treated in Poznan Department of Toxicology in 2010].
Przeglad lekarski 20110101
-
Intravenous silibinin as 'rescue treatment' for on-treatment non-responders to pegylated interferon/ribavirin combination therapy.
Antiviral therapy 20110101
-
[Hepatoprotectors in therapy of the alcoholic liver disease (clinical and experimental research)].
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101
-
Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
Chemico-biological interactions 20101205
-
Natural antioxidants synergistically enhance the anticancer potential of AP9-cd, a novel lignan composition from Cedrus deodara in human leukemia HL-60 cells.
Chemico-biological interactions 20101205
-
Silymarin, a natural antioxidant, protects cerebral cortex against manganese-induced neurotoxicity in adult rats.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20101201
-
Alginate-based ferrofluid and magnetic microsphere thereof.
International journal of biological macromolecules 20101201
-
Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutation.
Molecular cancer therapeutics 20101201
-
Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3).
Cell cycle (Georgetown, Tex.) 20101115
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
Inhibitory effect of silibinin on tumour necrosis factor-alpha and hydrogen peroxide production by human monocytes.
Natural product research 20101101
-
Milk thistle in liver diseases: past, present, future.
Phytotherapy research : PTR 20101001
-
Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules.
Pharmaceutical research 20101001
-
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20101001
-
Oral supplementation of silibinin prevents colon carcinogenesis in a long term preclinical model.
European journal of pharmacology 20100915
-
Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 20100915
-
Silibinin can induce differentiation as well as enhance vitamin D3-induced differentiation of human AML cells ex vivo and regulates the levels of differentiation-related transcription factors.
Hematological oncology 20100901
-
Silymarin protects PBMC against B(a)P induced toxicity by replenishing redox status and modulating glutathione metabolizing enzymes--an in vitro study.
Toxicology and applied pharmacology 20100901
-
Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.
Cancer metastasis reviews 20100901
-
Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants.
Cancer biology & therapy 20100815
-
Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Journal of cellular biochemistry 20100801
-
Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells.
Nutrition and cancer 20100801
-
Benzylpenicillin, acetylcysteine and silibinin as antidotes in human hepatocytes intoxicated with alpha-amanitin.
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20100701
-
Effects of silybinin, CYP3A4 and P-glycoprotein inhibitor in vitro, on the bioavailability of loratadine in rats.
Die Pharmazie 20100701
-
Protective effects of silybin and analogues against X-ray radiation-induced damage.
Acta biochimica et biophysica Sinica 20100701
-
Amatoxin poisoning treatment decision-making: pharmaco-therapeutic clinical strategy assessment using multidimensional multivariate statistic analysis.
Toxicon : official journal of the International Society on Toxinology 20100615
-
Downregulation of nuclear factor-kappa B (NF-kappaB) pathway by silibinin in human monocytes challenged with Paracoccidioides brasiliensis.
Life sciences 20100605
-
Silibinin ameliorates oxidative stress induced aberrant crypt foci and lipid peroxidation in 1, 2 dimethylhydrazine induced rat colon cancer.
Investigational new drugs 20100601
-
A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
The Prostate 20100601
-
Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.
Toxicology and applied pharmacology 20100601
-
Involvement of multiple molecular events in pyrogallol-induced hepatotoxicity and silymarin-mediated protection: evidence from gene expression profiles.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20100601
-
Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
Oncology reports 20100601
-
Multiple effects of silymarin on the hepatitis C virus lifecycle.
Hepatology (Baltimore, Md.) 20100601
-
Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles.
Acta pharmacologica Sinica 20100601
-
Preparation and in vitro evaluation of povidone-sodium cholate-phospholipid mixed micelles for the solubilization of poorly soluble drugs.
Archives of pharmacal research 20100601
-
Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin.
Drug development and industrial pharmacy 20100501
-
Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma.
Cancer letters 20100501
-
Evaluation of the genotoxic and anti-genotoxic activities of silybin in human hepatoma cells (HepG2).
Mutagenesis 20100501
-
Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy.
Medical hypotheses 20100501
-
Establishment of a methodology for investigating protectants against ethanol-induced hepatotoxicity.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20100501
-
Silibinin induces the generation of nitric oxide in human breast cancer MCF-7 cells.
Free radical research 20100501
-
Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
Neoplasia (New York, N.Y.) 20100501
-
[Protective effect of silibinin on liver injury induced by antituberculosis drugs].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100501
-
[An updated review at molecular pharmacological level for the mechanism of anti-tumor, antioxidant and immunoregulatory action of silibinin].
Yao xue xue bao = Acta pharmaceutica Sinica 20100401
-
Identification of hepatoprotective flavonolignans from silymarin.
Proceedings of the National Academy of Sciences of the United States of America 20100330
-
Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
Cancer research 20100315
-
Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Behavioural brain research 20100305
-
Involvement of mitochondria mediated pathways in hepatoprotection conferred by Fumaria parviflora Lam. extract against nimesulide induced apoptosis in vitro.
Toxicology in vitro : an international journal published in association with BIBRA 20100301
-
Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators.
Molecular carcinogenesis 20100301
-
Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
The Journal of pharmacology and experimental therapeutics 20100301
-
Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
Carcinogenesis 20100301
-
Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Gastroenterology 20100301
-
A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis.
The Journal of pharmacology and experimental therapeutics 20100301
-
Silibinin--a promising new treatment for cancer.
Anti-cancer agents in medicinal chemistry 20100301
-
Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix metalloproteinase 9.
Anti-cancer drugs 20100301
-
Targeting silibinin in the antiproliferative pathway.
Expert opinion on investigational drugs 20100201
-
Glycine pretreatment ameliorates liver injury after partial hepatectomy in the rat.
Journal of investigative surgery : the official journal of the Academy of Surgical Research 20100201
-
Radioprotection of plasmid and cellular DNA and Swiss mice by silibinin.
Mutation research 20100101
-
Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells.
Free radical research 20100101
-
Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.
Anticancer research 20100101
-
Silibinin induced autophagic and apoptotic cell death in HT1080 cells through a reactive oxygen species pathway.
Journal of pharmacological sciences 20100101
-
Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
Pharmacology 20100101
-
Herb-drug interaction of silymarin or silibinin on the pharmacokinetics of trazodone in rats.
Chemico-biological interactions 20091210
-
Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells.
Biochemical and biophysical research communications 20091204
-
Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway.
Pharmaceutical research 20091201
-
Self-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybin.
Journal of drug targeting 20091201
-
Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells.
Journal of ethnopharmacology 20091112
-
Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway.
Molecules (Basel, Switzerland) 20091026
-
Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
The Journal of pharmacology and experimental therapeutics 20091001
-
The protective effect of silibinin against mitomycin C-induced intrinsic apoptosis in human melanoma A375-S2 cells.
Journal of pharmacological sciences 20091001
-
Influence of exogenous salicylic acid on flavonolignans and lipoxygenase activity in the hairy root cultures of Silybum marianum.
Cell biology international 20090901
-
Silibinin modulates biotransforming microbial enzymes and prevents 1,2-dimethylhydrazine-induced preneoplastic changes in experimental colon cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20090901
-
Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties.
Bioorganic & medicinal chemistry 20090901
-
Free radical scavenging reactions and antioxidant activities of silybin: mechanistic aspects and pulse radiolytic studies.
Free radical research 20090901
-
Silibinin inhibits osteoclast differentiation mediated by TNF family members.
Molecules and cells 20090901
-
Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo.
Neurochemical research 20090801
-
Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice.
British journal of pharmacology 20090801
-
Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
Acta pharmacologica Sinica 20090801
-
Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.
Molecular cancer therapeutics 20090801
-
Micronization of silybin by the emulsion solvent diffusion method.
International journal of pharmaceutics 20090706
-
Acute liver acetaminophen toxicity in rabbits and the use of antidotes: a metabonomic approach in serum.
Journal of applied toxicology : JAT 20090701
-
Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin.
Gastroenterology 20090701
-
Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.
Phytomedicine : international journal of phytotherapy and phytopharmacology 20090601
-
Silibinin inhibits translation initiation: implications for anticancer therapy.
Molecular cancer therapeutics 20090601
-
The effect of silybin on passive avoidance learning and pathological changes in hippocampal CA1 and DG regions in male Wistar rats offspring.
Journal of Asian natural products research 20090601
-
Differential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysis.
Chemico-biological interactions 20090515
-
Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway.
International journal of molecular medicine 20090501
-
Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study.
Cancer research 20090501
-
Silibinin attenuates mast cell-mediated anaphylaxis-like reactions.
Biological & pharmaceutical bulletin 20090501
-
Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice.
World journal of gastroenterology 20090428
-
Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupffer cells.
Molecular nutrition & food research 20090401
-
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
Journal of natural products 20090401
-
Chemopreventive action of Lygodium flexuosum extract in human hepatoma PLC/PRF/5 and Hep 3B cells.
Journal of ethnopharmacology 20090318
-
AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids.
Chemico-biological interactions 20090316
-
Silibinin attenuates antigen-specific IgE production through the modulation of Th1/Th2 balance in ovalbumin-sensitized BALB/c mice.
Phytomedicine : international journal of phytotherapy and phytopharmacology 20090301
-
Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1.
Nitric oxide : biology and chemistry 20090201
-
Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
Oncogene 20090122
-
Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
Clinical cancer research : an official journal of the American Association for Cancer Research 20090115
-
Assessment of oxidative stress in leukocytes and granulocyte function following oral administration of a silibinin-phosphatidylcholine complex in cats.
American journal of veterinary research 20090101
-
Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.
Cancer prevention research (Philadelphia, Pa.) 20090101
-
Failure of benzylpenicillin, N-acetylcysteine and silibinin to reduce alpha-amanitin hepatotoxicity.
In vivo (Athens, Greece) 20090101
-
Pharmacokinetic interaction between oltipraz and silymarin in rats.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20090101
-
Optimisation of enzyme assisted extraction of silybin from the seeds of Silybum marianum by Box-Behnken experimental design.
Phytochemical analysis : PCA 20090101
-
Cosmeceuticals and silibinin.
Clinics in dermatology 20090101
-
Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin.
International journal of cancer 20081215
-
Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma.
Cancer letters 20081208
-
Medicinal flowers. XXIV. Chemical structures and hepatoprotective effects of constituents from flowers of Hedychium coronarium.
Chemical & pharmaceutical bulletin 20081201
-
The challenge of herbal therapies for prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 20081201
-
Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.
Gastroenterology 20081101
-
Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines.
Phytotherapy research : PTR 20081101
-
Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection.
Journal of medical virology 20081101
-
Fast repair activities towards dGMP hydroxyl radical adducts by silybin and its analogues.
Journal of radiation research 20081101
-
[Amanita poisoning--comparison of silibinin with a combination of silibinin and penicillin].
Deutsche medizinische Wochenschrift (1946) 20081001
-
Interspecies comparison of the glucuronidation processes in the man, monkey, pig, dog and rat.
Neuro endocrinology letters 20081001
-
Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.
The Annals of otology, rhinology, and laryngology 20081001
-
Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats.
Cancer prevention research (Philadelphia, Pa.) 20081001
-
Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation.
European journal of pharmacology 20080904
-
Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
Pharmaceutical research 20080901
-
Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
Cancer research 20080815
-
Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line.
Cell biology international 20080801
-
Synergistic antibacterial effect between silybin and N,N'-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates.
Journal of microbiology (Seoul, Korea) 20080801
-
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
European journal of pharmacology 20080728
-
Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse.
Cancer chemotherapy and pharmacology 20080701
-
Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
International journal of cancer 20080701
-
Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20080701
-
Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells.
Biological & pharmaceutical bulletin 20080701
-
Inhibition of insulin-like growth factor 1 receptor signaling enhanced silibinin-induced activation of death receptor and mitochondrial apoptotic pathways in human breast cancer MCF-7 cells.
Journal of pharmacological sciences 20080701
-
Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells.
Molecular cancer therapeutics 20080701
-
Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes.
Life sciences 20080523
-
Significantly greater antioxidant anticancer activities of 2,3-dehydrosilybin than silybin.
Biochimica et biophysica acta 20080501
-
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
European journal of cancer (Oxford, England : 1990) 20080401
-
Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
Cancer research 20080315
-
Hepatobiliary excretion of silibinin in normal and liver cirrhotic rats.
Drug metabolism and disposition: the biological fate of chemicals 20080301
-
Antioxidant and mitochondrial protective effects of silibinin in cold preservation-warm reperfusion liver injury.
Journal of ethnopharmacology 20080212
-
Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study.
The journal of physical chemistry. A 20080207
-
Preparative chromatographic purification of diastereomers of silybin and their quantification in human plasma by liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080201
-
In vitro evaluation and pharmacokinetics in dogs of solid dispersion pellets containing Silybum marianum extract prepared by fluid-bed coating.
Planta medica 20080201
-
Antifibrotic effects of a herbal combination regimen on hepatic fibrotic rats.
Phytotherapy research : PTR 20080101
-
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Clinical cancer research : an official journal of the American Association for Cancer Research 20080101
-
Preparation and properties of a silybin-phospholipid complex.
Die Pharmazie 20080101
-
Hepatoprotective effect of Cirsium arisanense Kitamura in tacrine-treated hepatoma Hep 3B cells and C57BL mice.
The American journal of Chinese medicine 20080101
-
Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells.
Anticancer research 20080101
-
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Carcinogenesis 20071201
-
Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Molecular cancer therapeutics 20071201
-
Vinpocetine ameliorates acute hepatic damage caused by administration of carbon tetrachloride in rats.
Acta biologica Hungarica 20071201
-
Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application.
Journal of pharmaceutical and biomedical analysis 20071130
-
Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Cancer research 20071115
-
Silybin is metabolized by cytochrome P450 2C8 in vitro.
Drug metabolism and disposition: the biological fate of chemicals 20071101
-
Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
The Journal of surgical research 20071101
-
Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco-2 cells.
The Journal of pharmacy and pharmacology 20071101
-
Effects and mechanisms of silibinin on human hepatoma cell lines.
World journal of gastroenterology 20071028
-
Hepatoprotective efficacy of certain flavonoids against microcystin induced toxicity in mice.
Environmental toxicology 20071001
-
p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.
Molecular cancer therapeutics 20071001
-
Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis.
Archives of pharmacal research 20071001
-
Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats.
Drug metabolism and disposition: the biological fate of chemicals 20070901
-
Comparative treatment of alpha-amanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and silybin in a murine model.
Annals of emergency medicine 20070901
-
Combinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms.
Acta pharmacologica Sinica 20070901
-
Effects of silibinin hemisuccinate on the intraocular pressure in normotensive rabbits.
Saudi medical journal 20070901
-
Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.
Cancer research 20070901
-
Renal and hepatic injury with elevated cardiac enzymes in Amanita phalloides poisoning: a case report.
Human & experimental toxicology 20070901
-
Propolis protects CYP 2E1 enzymatic activity and oxidative stress induced by carbon tetrachloride.
Molecular and cellular biochemistry 20070801
-
Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels.
BJU international 20070801
-
Protective effects of Cuscutae semen against dimethylnitrosamine-induced acute liver injury in Sprague-Dawley rats.
Biological & pharmaceutical bulletin 20070801
-
Preparation and characterization of solid lipid nanoparticles containing silibinin.
Drug delivery 20070801
-
Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
Carcinogenesis 20070701
-
Iron chelation or anti-oxidants prevent renal cell damage in the rewarming phase after normoxic, but not hypoxic cold incubation.
Cryobiology 20070601
-
Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
Acta pharmacologica Sinica 20070601
-
Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy.
Integrative cancer therapies 20070601
-
Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2.
Carcinogenesis 20070501
-
Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070501
-
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
International journal of cancer 20070501
-
Simultaneous determination of lithospermic acid B and its three metabolites by liquid chromatography/tandem mass spectrometry.
Journal of pharmaceutical and biomedical analysis 20070411
-
Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites.
Journal of agricultural and food chemistry 20070404
-
Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate.
Toxicological sciences : an official journal of the Society of Toxicology 20070401
-
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
Investigational new drugs 20070401
-
Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice.
Cancer research 20070401
-
[Amatoxin poisoning due to soup from personally picked deathcap mushrooms (Amanita phalloides)].
Nederlands tijdschrift voor geneeskunde 20070331
-
Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Biochemical and biophysical research communications 20070302
-
[Protective effect of silibinin against isoproterenol-induced injury to cardiac myocytes and its mechanism].
Yao xue xue bao = Acta pharmaceutica Sinica 20070301
-
Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines.
Carcinogenesis 20070201
-
Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells.
Journal of cellular physiology 20070201
-
Influence of silybin on biophysical properties of phospholipid bilayers.
Acta pharmacologica Sinica 20070201
-
Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3.
BJU international 20070201
-
Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Journal of gastroenterology and hepatology 20070101
-
Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
Archives of pharmacal research 20070101
-
(+)-Silybin, a pharmacologically active constituent of Silybum marianum: fragmentation studies by atmospheric pressure chemical ionization quadrupole time-of-flight tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 20070101
-
The flavonoid silibinin decreases glucose-6-phosphate hydrolysis in perfused rat hepatocytes by an inhibitory effect on glucose-6-phosphatase.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20070101
-
Influence of silymarin and its flavonolignans on H(2)O(2)-induced oxidative stress in human keratinocytes and mouse fibroblasts.
Burns : journal of the International Society for Burn Injuries 20061201
-
Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1.
Journal of pharmacological sciences 20061201
-
Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2.
Carcinogenesis 20061101
-
Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
The Indian journal of medical research 20061101
-
Silybin reduces lipid peroxidation of rat hepatocyte membrane caused by cyclosporin A.
Biochemistry. Biokhimiia 20061001
-
[Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].
Zhonghua yi xue za zhi 20060926
-
Silibinin protects rat cardiac myocyte from isoproterenol-induced DNA damage independent on regulation of cell cycle.
Biological & pharmaceutical bulletin 20060901
-
Differential effect of silibinin on E2F transcription factors and associated biological events in chronically UVB-exposed skin versus tumors in SKH-1 hairless mice.
Molecular cancer therapeutics 20060801
-
Synthesis and antioxidant evaluation of novel silybin analogues.
Journal of enzyme inhibition and medicinal chemistry 20060801
-
Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity.
Cancer letters 20060708
-
Silymarin inhibits UV radiation-induced immunosuppression through augmentation of interleukin-12 in mice.
Molecular cancer therapeutics 20060701
-
Effect of silibinin on the growth and progression of primary lung tumors in mice.
Journal of the National Cancer Institute 20060621
-
Prostate cancer chemoprevention by silibinin: bench to bedside.
Molecular carcinogenesis 20060601
-
Antiparasitic activity of flavonoids and isoflavones against Cryptosporidium parvum and Encephalitozoon intestinalis.
FEMS microbiology letters 20060601
-
Cadmium-induced apoptosis in murine macrophages is antagonized by antioxidants and caspase inhibitors.
Journal of toxicology and environmental health. Part A 20060601
-
Silibinin prevents UV-induced HaCaT cell apoptosis partly through inhibition of caspase-8 pathway.
Biological & pharmaceutical bulletin 20060601
-
Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry.
Journal of chromatography. A 20060526
-
Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats.
Journal of biomedical science 20060501
-
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
-
Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences.
Clinical cancer research : an official journal of the American Association for Cancer Research 20060501
-
Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells.
Molecular cancer therapeutics 20060501
-
Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenization.
Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20060501
-
MDR- and CYP3A4-mediated drug-herbal interactions.
Life sciences 20060327
-
Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway.
Journal of dental research 20060301
-
Silybin and dehydrosilybin inhibit cytochrome P450 1A1 catalytic activity: a study in human keratinocytes and human hepatoma cells.
Cell biology and toxicology 20060301
-
Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Oncogene 20060216
-
The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.
International journal of pharmaceutics 20060103
-
In vitro antimalarial activity of flavonoid derivatives dehydrosilybin and 8-(1;1)-DMA-kaempferide.
Acta tropica 20060101
-
Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro.
Phytomedicine : international journal of phytotherapy and phytopharmacology 20060101
-
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?].
Recenti progressi in medicina 20060101
-
Silibinin efficacy against human hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 20051201
-
Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.
Neoplasia (New York, N.Y.) 20051201
-
Hepatoprotective constituents of the edible brown alga Ecklonia stolonifera on tacrine-induced cytotoxicity in Hep G2 cells.
Archives of pharmacal research 20051201
-
Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation.
Toxicology 20051105
-
Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20051101
-
Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways.
Chemico-biological interactions 20051020
-
Protective effects of silybin on human umbilical vein endothelial cell injury induced by H2O2 in vitro.
Vascular pharmacology 20051001
-
[Progress in research of aldose reductase inhibitors in traditional medicinal herbs].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20051001
-
Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor up-regulation.
The Journal of surgical research 20050901
-
Mechanisms and preclinical efficacy of silibinin in preventing skin cancer.
European journal of cancer (Oxford, England : 1990) 20050901
-
Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5).
The FEBS journal 20050901
-
A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
Alternative medicine review : a journal of clinical therapeutic 20050901
-
Modulation of MRP1 protein transport by plant, and synthetically modified flavonoids.
Life sciences 20050826
-
Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-1 mouse skin.
Carcinogenesis 20050801
-
Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions.
FEMS immunology and medical microbiology 20050801
-
Dietary supplementation with silymarin inhibits 3,2'-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis in male F344 rats.
Clinical cancer research : an official journal of the American Association for Cancer Research 20050701
-
[Preparation of silybin-phospholipid complex and its bioavailability in rats].
Yao xue xue bao = Acta pharmaceutica Sinica 20050701
-
Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide.
Life sciences 20050624
-
Liquid chromatography/tandem mass spectrometry for the determination of magnesium lithospermate B in beagle dog serum.
Journal of pharmaceutical and biomedical analysis 20050601
-
[Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
Minerva gastroenterologica e dietologica 20050601
-
Silibinin up-regulates DNA-protein kinase-dependent p53 activation to enhance UVB-induced apoptosis in mouse epithelial JB6 cells.
The Journal of biological chemistry 20050527
-
Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
Basic & clinical pharmacology & toxicology 20050501
-
Dietary feeding of silibinin prevents early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20050501
-
Silibinin prevents cholestasis-associated retrieval of the bile salt export pump, Bsep, in isolated rat hepatocyte couplets: possible involvement of cAMP.
Biochemical pharmacology 20050401
-
Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis.
World journal of gastroenterology 20050227
-
Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
Oncogene 20050210
-
Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation.
Molecular cancer therapeutics 20050201
-
Potential utility of natural polyphenols for reversing fat-induced insulin resistance.
Medical hypotheses 20050101
-
Metal-induced oxidative damage in cultured hepatocytes and hepatic lysosomal fraction: beneficial effect of a curcumin/absinthium compound.
Chinese journal of digestive diseases 20050101
-
Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats.
Journal of biomedical science 20050101
-
Effect of silybin and its glycosides on the expression of cytochromes P450 1A2 and 3A4 in primary cultures of human hepatocytes.
Journal of biochemical and molecular toxicology 20050101
-
Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
Clinical cancer research : an official journal of the American Association for Cancer Research 20041215
-
A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.
Mutation research 20041102
-
Oxidised derivatives of silybin and their antiradical and antioxidant activity.
Bioorganic & medicinal chemistry 20041101
-
Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Carcinogenesis 20040901
-
Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
Cancer research 20040901
-
Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis.
Carcinogenesis 20040801
-
Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.
Molecular carcinogenesis 20040701
-
Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows.
Journal of dairy science 20040701
-
Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.
Drug metabolism and disposition: the biological fate of chemicals 20040601
-
Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity.
Pharmacological research 20040501
-
Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.
The Journal of urology 20040501
-
Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
Planta medica 20040501
-
Mercury-induced apoptosis and necrosis in murine macrophages: role of calcium-induced reactive oxygen species and p38 mitogen-activated protein kinase signaling.
Toxicology and applied pharmacology 20040401
-
Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Oncology reports 20040201
-
Prostate cancer prevention by silibinin.
Current cancer drug targets 20040201
-
Effect of silybin on phorbol myristate actetate-induced protein kinase C translocation, NADPH oxidase activity and apoptosis in human neutrophils.
Phytomedicine : international journal of phytotherapy and phytopharmacology 20040201
-
Dual efficacy of silibinin in protecting or enhancing ultraviolet B radiation-caused apoptosis in HaCaT human immortalized keratinocytes.
Carcinogenesis 20040101
-
Involvement of NF-kappaB and caspases in silibinin-induced apoptosis of endothelial cells.
International journal of molecular medicine 20040101
-
Silymarin extraction from milk thistle using hot water.
Applied biochemistry and biotechnology 20040101
-
Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
Biochemical and biophysical research communications 20031226
-
Comparative bioavailability of silibinin in healthy male volunteers.
International journal of clinical pharmacology and therapeutics 20031201
-
Effects of flavonoids on the resistance of microsomes to lipid peroxidation in vitro and ex vivo.
Bulletin of experimental biology and medicine 20031201
-
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Oncogene 20031113
-
[Amanita poisoning during pregnancy].
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20031101
-
Antioxidants protect primary rat hepatocyte cultures against acetaminophen-induced DNA strand breaks but not against acetaminophen-induced cytotoxicity.
Toxicology 20030930
-
Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
International journal of cancer 20030920
-
Application of liquid chromatography-electrospray ionization-ion trap mass spectrometry to investigate the metabolism of silibinin in human liver microsomes.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030905
-
Silibinin protects mice from T cell-dependent liver injury.
Journal of hepatology 20030901
-
Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20030901
-
Cytotoxicity of inorganic mercury in murine T and B lymphoma cell lines: involvement of reactive oxygen species, Ca(2+) homeostasis, and cytokine gene expression.
Toxicology in vitro : an international journal published in association with BIBRA 20030801
-
Gram-positive bacteria specific properties of silybin derived from Silybum marianum.
Archives of pharmacal research 20030801
-
Anti-angiogenic effect of silymarin on colon cancer LoVo cell line.
The Journal of surgical research 20030701
-
Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum.
Phytotherapy research : PTR 20030501
-
Mechanism-based in vitro screening of potential cancer chemopreventive agents.
Mutation research 20030101
-
Extraction of nutraceuticals from milk thistle: I. Hot water extraction.
Applied biochemistry and biotechnology 20030101
-
[St. Mary's Thistle: an overview].
Journal de pharmacie de Belgique 20030101
-
Preparation and pharmacological evaluation of silibinin liposomes.
Arzneimittel-Forschung 20030101
-
Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.
Anticancer research 20030101
-
Primary human hepatocytes are protected against prolonged and repeated exposure to ethanol by silibinin-dihemisuccinate.
Alcohol and alcoholism (Oxford, Oxfordshire) 20030101
-
Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line.
Cancer biology & therapy 20030101
-
Silibinin: a thorny therapeutic for EGF-R expressing tumors?
Cancer biology & therapy 20030101
-
Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
The Prostate 20021101
-
Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities.
Phytotherapy research : PTR 20021101
-
Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 20021101
-
Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.
Diabetes, nutrition & metabolism 20020801
-
Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
Molecular cancer therapeutics 20020501
-
Impact of in utero exposure to EtOH on corpus callosum development and paw preference in rats: protective effects of silymarin.
BMC complementary and alternative medicine 20020101
-
The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells.
Cell cycle (Georgetown, Tex.) 20020101
-
Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships.
Journal of medicinal chemistry 20010118
-
Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin.
Carcinogenesis 20000401
-
Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells.
The Journal of pharmacology and experimental therapeutics 19990901
-
Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Hepatology (Baltimore, Md.) 19970901
-
Inhibition of reverse transcriptases by flavonoids.
Antiviral research 19890901
-
[Effectiveness of legalon and essentiale in a tetracycline-induced liver lesion].
Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology 19861001